They performed proof-of-concept experiments knocking down postsynaptic density protein 95, which plays a role in synaptic plasticity; ??-synuclein, which is implicated in neurodegenerative disorders such as Parkinson???s disease; and death associated protein kinase 1 (DAPK1), which is activated by stroke.